We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VRDN market cap is 1.54B. The company's latest EPS is USD -3.0012 and P/E is -6.48.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 72k | 72k | 72k | 72k | 86k |
| Operating Income | -51.22M | -71.48M | -55.9M | -72.19M | -83.48M |
| Net Income | -47.66M | -66.86M | -48.54M | -64.99M | -76.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.46M | 1.05M | 2.96M | 1.77M | 314k |
| Operating Income | -41.98M | -110.38M | -79.73M | -134.3M | -254.45M |
| Net Income | -41.87M | -110.72M | -79.41M | -129.87M | -237.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 328.76M | 490.42M | 630.38M | 585.66M | 771.9M |
| Total Liabilities | 45.18M | 48.4M | 47.85M | 56.33M | 64.4M |
| Total Equity | 283.58M | 442.02M | 582.53M | 529.34M | 707.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.26M | 131.26M | 203.71M | 435.09M | 490.42M |
| Total Liabilities | 14.51M | 11.22M | 15.99M | 40.03M | 48.4M |
| Total Equity | 15.75M | -60.76M | 187.72M | 395.06M | 442.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -146.17M | -184.17M | -45.22M | -91.28M | -158.99M |
| Investing | 75.46M | -94.25M | -143.05M | -81.07M | -165.74M |
| Financing | 26.73M | 225.67M | 177.08M | 177.19M | 423.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.06M | -29.78M | -54.58M | -93.84M | -184.17M |
| Investing | 28.23M | -50.48M | -74.29M | -115.13M | -94.25M |
| Financing | 70k | 101.31M | 125.28M | 322.24M | 225.67M |
| Market Cap | 1.54B |
| Price to Earnings Ratio | -6.48 |
| Price to Sales Ratio | 4.86k |
| Price to Cash Ratio | 14.98 |
| Price to Book Ratio | 3.49 |
| Dividend Yield | - |
| Shares Outstanding | 79.21M |
| Average Volume (1 week) | 1.8M |
| Average Volume (1 Month) | 1.76M |
| 52 Week Change | -14.32% |
| 52 Week High | 27.20 |
| 52 Week Low | 11.40 |
| Spread (Intraday) | 2.45 (11.95%) |
| Company Name | Viridian Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.viridiantherapeutics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
